|
Volumn 178, Issue 12, 2003, Pages 655-656
|
Screening for ovarian cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CA 125 ANTIGEN;
GLYCOPROTEIN;
PROTEIN;
CANCER SCREENING;
CANCER SURVIVAL;
CAUSE OF DEATH;
COST EFFECTIVENESS ANALYSIS;
COUNSELING;
DOPPLER FLOWMETRY;
ENDOMETRIUM CANCER;
FAMILY HISTORY;
FEMALE;
FEMALE GENITAL TRACT TUMOR;
GENE EXPRESSION;
GENE MUTATION;
GENOMICS;
HEALTH CARE COST;
HIGH RISK POPULATION;
HUMAN;
MEDICAL CARE;
MENOPAUSE;
MORBIDITY;
OVARY CANCER;
OVARY CARCINOMA;
PELVIS;
PHYSICAL EXAMINATION;
POSTMENOPAUSE;
PREDICTION;
PROTEOMICS;
QUALITY OF LIFE;
SCREENING TEST;
SHORT SURVEY;
TRANSVAGINAL ECHOGRAPHY;
UNITED KINGDOM;
UNITED STATES;
|
EID: 0038505360
PISSN: 0025729X
EISSN: None
Source Type: Journal
DOI: 10.5694/j.1326-5377.2003.tb05399.x Document Type: Short Survey |
Times cited : (25)
|
References (9)
|